SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Statistical Methods in Medical Research
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
0962280207081863v1
0962280207081863v2
17/5/477    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Green, E.M.
Right arrow Articles by Sargent, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, E.M.
Right arrow Articles by Sargent, D. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Clinical Trials
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Surrogate endpoint validation: statistical elegance versus clinical relevance

E.M. Green1, G. Yothers2, and D. J. Sargent3*

1 Division of Biostatistics, Mayo Clinic, Rochester, MN, USA
2 NSABP Statistical Center, Pittsburgh, PA, USA
3 Division of Biostatistics, MayoClinic, Rochester, MN, USA

* To whom correspondence should be addressed.


   Abstract

A variety of approaches have been proposed to provide formal and informal validation of proposed surrogate markers. To achieve true clinical impact, the validation must convince both the statistical and clinical communities. In this paper, we argue that the best approach is not a single method but a multi-faceted exploration, using multiple approaches, including those that directly appeal to clinicians but with less statistical foundation and those arising from statistical considerations but more difficult to interpret clinically. We illustrate our approach using data from clinical trials in both early and advanced colorectal cancer.

First published on February 19, 2008, doi:10.1177/0962280207081863

Statistical Methods in Medical Research 2008;17:477.

A more recent version of this article appeared on October 1, 2008
This version was published on February 25, 2008


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Stat Methods Med ResHome page
P. Piedbois and J. Miller Croswell
Surrogate endpoints for overall survival in advanced colorectal cancer: a clinician's perspective
Statistical Methods in Medical Research, October 1, 2008; 17(5): 519 - 527.
[Abstract] [PDF]



Advertisement